Drug Type Interleukins, Biosimilar |
Synonyms IL-KTM, PB (RA) 2010, PB (RA)-2010 |
Target |
Action antagonists |
Mechanism IL1R1 antagonists(Interleukin-1 receptor alpha antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Rheumatoid Arthritis | Preclinical | Finland | 07 May 2024 |






